GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » EBIT

RVP (Retractable Technologies) EBIT : $-7.21 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies EBIT?

Retractable Technologies's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $-1.92 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $-7.21 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Retractable Technologies's annualized ROC % for the quarter that ended in Sep. 2024 was -17.77%. Retractable Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -6.91%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Retractable Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 44.22%.


Retractable Technologies EBIT Historical Data

The historical data trend for Retractable Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies EBIT Chart

Retractable Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 26.33 75.18 5.33 -8.76

Retractable Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.26 -0.01 0.55 -5.82 -1.92

Competitive Comparison of Retractable Technologies's EBIT

For the Medical Instruments & Supplies subindustry, Retractable Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's EV-to-EBIT falls into.



Retractable Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Retractable Technologies  (AMEX:RVP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Retractable Technologies's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-20.544 * ( 1 - 1.59% )/( (112.971 + 114.604)/ 2 )
=-20.2173504/113.7875
=-17.77 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Retractable Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-7.692/( ( (90.05 + max(20.481, 0)) + (88.937 + max(23.25, 0)) )/ 2 )
=-7.692/( ( 110.531 + 112.187 )/ 2 )
=-7.692/111.359
=-6.91 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.69 + 22.018 + 0.878) - (5.868 + 0.3 + 0.937)
=20.481

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.675 + 21.301 + 0.96799999999999) - (6.504 + 0.38 + 0.81)
=23.25

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Retractable Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=-7.207/-16.297
=44.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Retractable Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Retractable Technologies Business Description

Traded in Other Exchanges
N/A
Address
511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
Executives
Thomas J Shaw director, 10 percent owner, officer: President and CEO 511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard 10 percent owner 156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr director 816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley director 1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman director, officer: Vice President of Sales 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii director, officer: Chief Financial Officer 511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack director 1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut director 1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno 10 percent owner 777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August 10 percent owner 340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner director, officer: Exec. VP, Eng & Prod. 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza director P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu director 511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King director 9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios officer: Vice President/General Counsel 511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies Headlines